EUVIMEDEUVIMED entdecken
Crossref

Optimization of immune checkpoint inhibitor treatment planning for relapsed or refractory extranodal NK/T cell lymphoma

Sang Eun Yoon, Hyungwoo Cho, Philipp Berning, Junhun Cho, Hyun-Young Kim, Dok Hyun Yoon, Norbert Schmit, Seok Jin Kim, Won Seog Kim

Annals of Hematology · 2024

DOI: 10.1007/s00277-024-05739-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, 2024. Verfasst von Sang Eun Yoon und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Lymphoma, Extranodal NK-T-Cell, Immune Checkpoint Inhibitors, Antibodies, Monoclonal, Humanized. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Extranodal NK-T-CellImmune Checkpoint InhibitorsAntibodies, Monoclonal, HumanizedHumansMaleFemaleMiddle AgedAgedAdultRetrospective StudiesSalvage TherapyPositron Emission Tomography Computed TomographyYoung AdultAged, 80 and overSurvival RateHerpesvirus 4, Human

Stichwörter der Autor:innen

Epstein-Barr virusImmune checkpoint inhibitorsPembrolizumabRelapsed/refractory extranodal NK/T cell lymphoma

Substanzen

Immune Checkpoint InhibitorsAntibodies, Monoclonal, Humanizedpembrolizumab

Autor:innen und Institutionen

  • Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Department of Hematology and Oncology, University Hospital Muenster, Muenster, Germany.
  • Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. wskimsmc@skku.edu.

Zitieren

APA

Yoon, S. E., Cho, H., Berning, P., Cho, J., Kim, H. Y., Yoon, D. H., Schmit, N., Kim, S. J., & Kim, W. S. (2024). Optimization of immune checkpoint inhibitor treatment planning for relapsed or refractory extranodal NK/T cell lymphoma. Annals of Hematology. https://doi.org/10.1007/s00277-024-05739-3

Vancouver

Yoon SE, Cho H, Berning P, Cho J, Kim HY, Yoon DH, et al. Optimization of immune checkpoint inhibitor treatment planning for relapsed or refractory extranodal NK/T cell lymphoma. Annals of Hematology. 2024. doi:10.1007/s00277-024-05739-3

BibTeX
@article{Yoon2024,
  author = {Yoon, Sang Eun and Cho, Hyungwoo and Berning, Philipp and Cho, Junhun and Kim, Hyun-Young and Yoon, Dok Hyun and Schmit, Norbert and Kim, Seok Jin and Kim, Won Seog},
  title = {Optimization of immune checkpoint inhibitor treatment planning for relapsed or refractory extranodal NK/T cell lymphoma},
  journal = {Annals of Hematology},
  year = {2024},
  doi = {10.1007/s00277-024-05739-3}
}
Kostenlos starten →